Most patients are first diagnosed with heart failure in an emergency room or hospital, when their symptoms are already severe. This advanced algorithm could change all that by opening up screening to many more patients. 

The question of legal responsibility for AI gone wrong in healthcare remains unsettled. The only sure thing is a lot of finger pointing. 

Wearable health devices outfitted with AI seem poised to transition from consumer novelties to an integral layer of U.S. public-health intelligence. 

Ultromics plans to use the new funds to help expand its presence throughout the United States. In addition, the company is focused on developing additional AI-enabled software offerings.

These findings could have positive implications for regions with diverse patient populations, authors of a new analysis suggest.

Or maybe the White House’s AI Action Plan will spur a mix of positive opportunities, negative challenges—and neutral adjustments.

California-based Heartflow, which offers an AI software that assesses coronary CT angiography scans, hopes to raise over $200 million through the stock offering. 

PressGaney market researchers offer three observations on the technology’s potential for optimizing patient satisfaction—and, with it, subsequent ‘PX’ scores.